↓ Skip to main content

Wellness and the Role of Comorbidities in Multiple Sclerosis

Overview of attention for article published in Neurotherapeutics, October 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news
1 news outlet
twitter
14 X users
facebook
4 Facebook pages

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
201 Mendeley
Title
Wellness and the Role of Comorbidities in Multiple Sclerosis
Published in
Neurotherapeutics, October 2017
DOI 10.1007/s13311-017-0563-6
Pubmed ID
Authors

Brandon P Moss, Mary R Rensel, Carrie M Hersh

Abstract

Multiple sclerosis (MS) is a demyelinating and neurodegenerative disorder of the central nervous system, for which disease modifying therapies (DMTs) are the mainstay treatment approach to reduce inflammatory disease activity and slow worsening disability. In addition to conventional pharmacologic therapy, there is growing interest in the use of lifestyle strategies to support wellness and mitigate disease-related complications in MS. This interest stems from a growing appreciation of the role of certain comorbidities and lifestyle factors on disease activity, disability, mortality, and overall quality of life. While the current literature is not conclusive, there is evidence to suggest a potential role for vitamin D supplementation, tobacco smoking cessation, routine exercise, a plant-based, anti-inflammatory diet, and maintenance of emotional well-being as adjunct therapies to DMTs. In addition to DMTs, lifestyle strategies should be emphasized as part of a management plan focused on overall health and well-being.

X Demographics

X Demographics

The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 201 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 201 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 29 14%
Student > Master 22 11%
Student > Ph. D. Student 17 8%
Researcher 14 7%
Student > Doctoral Student 11 5%
Other 33 16%
Unknown 75 37%
Readers by discipline Count As %
Medicine and Dentistry 41 20%
Nursing and Health Professions 24 12%
Neuroscience 12 6%
Psychology 12 6%
Pharmacology, Toxicology and Pharmaceutical Science 6 3%
Other 19 9%
Unknown 87 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 August 2023.
All research outputs
#1,934,895
of 25,382,440 outputs
Outputs from Neurotherapeutics
#165
of 1,308 outputs
Outputs of similar age
#37,481
of 331,218 outputs
Outputs of similar age from Neurotherapeutics
#6
of 25 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,308 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.2. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 331,218 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.